Ophira Ginsburg named director of NYU cancer center’s High Risk Program

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Ophira Ginsburg has joined NYU Langone’s Perlmutter Cancer Center as director of its new High Risk Program, which identifies, studies and cares for patients with hereditary syndromes that increase cancer risk.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

More than half of deaths that are not attributed to disease progression or recurrence after CAR T-cell therapy are caused by infections—an unprecedented finding that experts say marks a shift from a conventional focus on mitigating treatment-specific adverse events to including prevention and management of infections.

Login